go 6976 and sb 216763

go 6976 has been researched along with sb 216763 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N1
Brunner-Weinzierl, MC; Hollenbach, E; Kandolf, R; Kavuri, S; Klar, S; Klingel, K; Leverkus, M; Neumann, M; Wilisch-Neumann, A1

Other Studies

2 other study(ies) available for go 6976 and sb 216763

ArticleYear
The selectivity of protein kinase inhibitors: a further update.
    The Biochemical journal, 2007, Dec-15, Volume: 408, Issue:3

    Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera

2007
Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation.
    Oncogene, 2011, May-26, Volume: 30, Issue:21

    Topics: Carbazoles; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunoblotting; Immunoprecipitation; Indoles; Jurkat Cells; Maleimides; Mutation; Phosphorylation; Protein Binding; Protein Kinase C; Pyrroles; RNA Interference; Signal Transduction; Substrate Specificity; Transcription Factor RelB

2011